Aihc Capital Management LTD 13F holdings, Q2 2026
Holdings as of June 30, 2026 · filings on SEC EDGAR · this is the latest filing on record
Aihc Capital Management LTD disclosed 4 US equity positions worth $104.2m in its Q2 2026 13F filing. The largest position was RVMD at 54.5% of the reported book, followed by ORIC and NBP. Against the Q1 2026 filing, it opened 0 new positions, added to 2 and reduced 1 among the top 4 holdings.
What did Aihc Capital Management LTD own in Q2 2026? Top 4 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2026 |
|---|---|---|---|---|---|---|---|
| 1 | RVMD REVOLUTION MEDICINES INC | Healthcare | 54.5% | $56.8m | 303,133 | -63% | reduced |
| 2 | ORIC ORIC PHARMACEUTICALS INC | Healthcare | 39.8% | $41.5m | 3,828,460 | 56% | added |
| 3 | NBP NOVABRIDGE BIOSCIENCES | Healthcare | 5.4% | $5.6m | 2,878,033 | 27% | added |
| 4 | KRRO KORRO BIO INC | Healthcare | 0.4% | $398.9k | 30,265 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.